EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study

Carly Herbert iD, Annukka A R Antar iD, John Broach, Colton Wright, Pamela Stamegna, Katherine Luzuriaga, Nathaniel Hafer iD, David D McManus iD, Yukari C Manabe iD, Apurv Soni iD

Clinical Infectious Diseases · 05.02.2025 · 80 (1) · 82-90

DOI: 10.1093/cid/ciae539 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.12.2024. Verfasst von Carly Herbert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, Rapid Acceleration of Diagnostics (RADx) Tech program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral dynamics during acute infection and the development of long coronavirus disease 2019 (COVID-19), or “long COVID,” is largely unknown.

Methods

Between October 2021 and February 2022, 7361 people not known to have COVID-19 self-collected nasal swab samples for SARS-CoV-2 reverse-transcription polymerase chain reaction testing every 24–48 hours for 10–14 days. Participants whose first known SARS-CoV-2 infection was detected were surveyed for long COVID in August 2023. Their slopes of viral clearance were modeled using linear mixed effects models with random slopes and intercepts, and the relative risk (RR) of long COVID based on viral slopes was calculated using a log binomial model, adjusted for age, symptoms, and variant. Sex-based interaction terms were also evaluated for significance.

Results

A total of 172 participants were eligible for analyses, and 59 (34.3%) reported long COVID. The risk of long COVID with 3–4 symptoms (adjusted RR, 2.44 [95% confidence interval, .88–6.82]) and ≥5 symptoms (4.97 [1.90–13.0]) increased with each unit increase in slope of viral clearance. While the probability of long COVID increased with slowed viral clearance among women, the same relationship was not observed among men (interaction term: P = .02). Acute SARS-CoV-2 symptoms of abdominal pain (adjusted RR, 5.41 [95% confidence interval, 2.44–12.0]), nausea (3.01 [1.31–6.89]), and body aches (2.58 [1.26–5.30]) were most strongly associated with long COVID.

Conclusions

We observed that slower viral clearance rates during acute COVID-19 were associated with increased risk and more symptoms of long COVID . Early viral-host dynamics appear to be mechanistically linked to the development of long COVID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansMaleFemaleMiddle AgedAdultCohort StudiesAgedViral LoadPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19SARS-CoV-2long COVIDviral clearanceviral persistence

Autor:innen und Institutionen

  • Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • University of Massachusetts Center for Clinical and Translational Science, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Division of Infectious Disease, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Division of Health System Science, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

ORCID-Profile: Carly Herbert, Annukka A R Antar, Nathaniel Hafer, David D McManus, Yukari C Manabe, Apurv Soni

Förderung

  • NCATS NIH HHS
  • NIH HHS
  • Rapid Acceleration of Diagnostics (RADx) Tech program
  • NIBIB NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Herbert, C., Antar, A. A. R., Broach, J., Wright, C., Stamegna, P., Luzuriaga, K., Hafer, N., McManus, D. D., Manabe, Y. C., & Soni, A. (2025). Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study. Clinical Infectious Diseases, 80(1), 82-90. https://doi.org/10.1093/cid/ciae539

Vancouver

Herbert C, Antar AAR, Broach J, Wright C, Stamegna P, Luzuriaga K, et al. Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study. Clinical Infectious Diseases. 2025;80(1):82-90. doi:10.1093/cid/ciae539

BibTeX
@article{Herbert2025,
  author = {Herbert, Carly and Antar, Annukka A R and Broach, John and Wright, Colton and Stamegna, Pamela and Luzuriaga, Katherine and Hafer, Nathaniel and McManus, David D and Manabe, Yukari C and Soni, Apurv},
  title = {Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {80},
  number = {1},
  pages = {82--90},
  doi = {10.1093/cid/ciae539}
}
Kostenlos starten →